Dr. Sewunet Admasu Belachew (BPharm, MSc, PhD) is a postdoctoral research fellow in the FNCWR Program at the University of Queensland. His research primarily centres around the quality and equity of cancer care pathways, with a special emphasis on improving healthcare access for Aboriginal and Torres Strait Islander peoples.

He is involved in the investigation of the risk of cardiovascular events and outcomes among Australians with a cancer diagnosis. He takes the lead and collaborates with a team in undertaking various systematic reviews and meta-analyses related to cancer care and outcomes.

Before pursuing his PhD, Dr. Belachew served as a lecturer, clinical preceptor, and mentor/supervisor at the University of Gondar in Ethiopia, where he taught courses such as pharmacotherapy, pharmacoepidemiology, and clinical pharmacy practice. In 2023, he completed his PhD at the University of Queensland. Since 2015, he has published over 40 peer-reviewed articles. His research has garnered attention from esteemed institutions such as the World Health Organization, underscoring the significance of his contributions to shaping policy and practice. During his PhD study, he worked as a research assistant at Menzies Health Institute-Centre for Applied Health Economics, Griffith University.

Dr. Belachew has been invited to speak in numerous scientific research meetings, including the Annual Symposium on Global Cancer Research organised by the National Cancer Institute of the USA and the International Congress of Antimicrobial Chemotherapy in Perth, Australia. He has also collaborated with colleagues to secure research grants. He is an executive member of the Professional Society for Health Economics and Outcomes Research (ISPOR) Ethiopian regional chapter and a board member of the Ethiopian Organisation for Cancer Prevention and Research. Moreover, he is also one of the few Ethiopian Young African Leadership Initiative (YALI) alumni.